Associations between VDR gene polymorphisms and colorectal cancer susceptibility: an updated meta-analysis based on 39 case-control studies
Metrics: PDF 579 views | HTML 1141 views | ?
Zhipeng Pan1,*, Mengya Chen2,3,*, Xingxing Hu2,3, Hua Wang1, Jiajia Yang2,3, Congjun Zhang1, Faming Pan2,3 and Guoping Sun1
1Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230032, China
2Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, 230032, China
3The Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei, Anhui, 230032, China
*These authors contributed equally to this work and should be considered co-first authors
Guoping Sun, email: sunguoping@ ahmu.edu.cn
Faming Pan, email: firstname.lastname@example.org
Keywords: vitamin D receptor; colorectal cancer; VDR; meta-analysis; polymorphisms
Received: July 26, 2017 Accepted: November 14, 2017 Published: January 04, 2018
Background: Recent studies have reported the associations between vitamin D receptor (VDR) polymorphisms and colorectal cancer (CRC), but the results were not always consistent. This meta-analysis aims to evaluate whether VDR polymorphisms are associated with CRC susceptibility.
Materials And Methods: Studies on the associations between VDR polymorphisms and CRC were retrieved from the Web of Science, PubMed, the Chinese Biomedical Database (CBM), Chinese National Knowledge Infrastructure (CNKI) and Wanfang (Chinese) databases. The odds ratio (OR) with 95% confidence intervals (CIs) was obtained.
Results: Thirty-nine articles met all inclusion criteria and were included in the meta-analysis including 22101 CRC cases and 23696 healthy controls. The 39 articles consisted of five VDR gene polymorphisms including ApaI, FokI, BsmI, TaqI and Cdx2. The results of meta-analysis showed that the FokI polymorphism was on the fringe of statistically significant in the comparisons of F allele vs. f allele in fixed model (OR = 1.029, 95% CI = 0.999–1.059, Praw = 0.057, PFDR = 0.057). Moreover, for the associations between BsmI polymorphism with CRC, We observed significant differences in allele frequencies, the homozygous model and the dominant model between CRC patients and healthy controls (B vs. b: OR = 0.862, 95% CI = 0.761–0.976, Praw = 0.019, PFDR = 0.019; BB vs. bb: OR = 0.786, 95% CI = 0.636–0.972, Praw = 0.026, PFDR = 0.039; BB + Bb vs. bb: OR = 0.934, 95% CI = 0.888-0.982, Praw = 0.008, PFDR = 0.024, respectively).
Conclusions: This meta-analysis suggests that BsmI is associated with CRC risk and FokI might be a risk factor for CRC. However, these associations with CRC need further studied.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.